Hegseth's low-T screening may affect up to 25 percent of Army, study finds
A new study in JAMA suggests that up to a quarter of active-duty Army members could receive a low testosterone result from mandatory screening. The true prevalence of the condition is likely a fraction of this figure.
A new study published in JAMA raises concerns about the U.S. Army's planned mandatory screening for low testosterone. According to the findings, up to 25 percent of active-duty service members could receive a low testosterone result, despite the actual prevalence of the condition likely being a significantly smaller fraction.
The study amplifies worries that the mandatory screening, announced by Defense Secretary Pete Hegseth in July, will lead to a cascade of unnecessary medical evaluations. Experts fear these evaluations could result in inappropriate testing, inaccurate diagnoses, and overtreatment that may cause harm, including infertility.
Leading medical societies, including the Endocrine Society and the American Urological Association (AUA), have previously recommended against such blanket screenings for individuals without symptoms. Nevertheless, the Pentagon has proceeded with the plan, releasing clinical guidance in September.
The JAMA research highlights why testosterone levels are typically not measured in asymptomatic men and offers a glimpse into how many Army members might become subjected to this clinically questionable screening.